Pancreatic Cancer Research

ResearcherHammersmith HospitalActive in the last 2 years

Nagy Adley Habib

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4920-4154; OpenAlex author ID A5053323102. Sources: OpenAlex.

Their work

Papers
16 (first author 0, last author 4)
Trials
0
Grants
0
Labs led
1
Collaborators
36
Papers, trials and grants by year

2012: 1 paper · 2013: 1 paper · 2014: none · 2015: 2 papers · 2016: 1 paper · 2017: none · 2018: 3 papers · 2019: 2 papers · 2020: 1 paper · 2021: none · 2022: 2 papers · 2023: none · 2024: 1 paper · 2025: 2 papers

Papers 16

  1. Redirecting venous flow from the superior mesenteric vein to the inferior mesenteric vein in resections for locally advanced pancreatic cancer. Co-author DOI 10.1007/s00423-025-03818-1↗
  2. Pancreatoduodenectomy with vascular reconstruction versus chemotherapy alone in patients with locally advanced pancreatic cancer: a systematic review. Last author DOI 10.1590/0102-67202025000021e1890↗
  3. Cannabidiol's cytotoxicity in pancreatic cancer is induced via an upregulation of ceramide synthase 1 and ER stress. Co-author DOI 10.1186/s42238-024-00227-x↗
  4. A case of improved quality of life in a patient with inoperable pancreatic cancer after repeated RFA. Last author DOI 10.1016/j.radcr.2022.07.017↗
  5. A Case Report on Longitudinal Collection of Tumour Biopsies for Gene Expression-Based Tumour Microenvironment Analysis from Pancreatic Cancer Patients Treated … Co-author DOI 10.3390/curroncol29100531↗
  6. Immunological combination treatment holds the key to improving survival in pancreatic cancer. Last author DOI 10.1007/s00432-020-03332-5↗
  7. Targeted Delivery of C/EBPα-saRNA by RNA Aptamers Shows Anti-tumor Effects in a Mouse Model of Advanced PDAC. Co-author DOI 10.1016/j.omtn.2019.08.017↗
  8. Can we predict long-term survival in resectable pancreatic ductal adenocarcinoma? Co-author DOI 10.18632/oncotarget.26511↗
  9. The use of radiofrequency ablation in pancreatic cancer in the midst of the dawn of immuno-oncology. Co-author DOI 10.1007/s12032-018-1209-1↗
  10. Radiofrequency assisted pancreaticoduodenectomy for palliative surgical resection of locally advanced pancreatic adenocarcinoma. Last author DOI 10.18632/oncotarget.24596↗
  11. Glypican-1 is enriched in circulating-exosomes in pancreatic cancer and correlates with tumor burden. Co-author DOI 10.18632/oncotarget.24873↗
  12. Targeted Delivery of C/EBPα -saRNA by Pancreatic Ductal Adenocarcinoma-specific RNA Aptamers Inhibits Tumor Growth In Vivo. Co-author DOI 10.1038/mt.2016.60↗
  13. Analysis of Endoscopic Radiofrequency Ablation of Biliary Malignant Strictures in Pancreatic Cancer Suggests Potential Survival Benefit. Co-author DOI 10.1007/s10620-015-3731-8↗
  14. microRNAs with prognostic significance in pancreatic ductal adenocarcinoma: A meta-analysis. Co-author DOI 10.1016/j.ejca.2015.04.006↗
  15. Safety and efficacy of radiofrequency ablation in the management of unresectable bile duct and pancreatic cancer: a novel palliation technique. Co-author DOI 10.1155/2013/910897↗
  16. Tumor infiltration in the medial resection margin predicts survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s11605-012-1985-4↗

Closest collaborators

The 25 strongest of 36 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Mikael Hans Sodergren · 6 shared papers, 2018–2024 · strength 0.90
  2. Nagina Mangal · 3 shared papers, 2020–2024 · strength 0.60
  3. Isabella Reccia · 4 shared papers, 2016–2025 · strength 0.52
  4. Kumar Jayant · 3 shared papers, 2018–2025 · strength 0.47
  5. Long R. Jiao · 6 shared papers, 2012–2020 · strength 0.42
  6. Jan Henrik Storkholm · 1 shared paper, 2025 · strength 0.37
  7. Stefan Kobbelgaard Burgdorf · 1 shared paper, 2025 · strength 0.37
  8. Anguraj Sadanandam · 2 shared papers, 2020–2022 · strength 0.29
  9. Adriano Carneiro da Costa · 1 shared paper, 2025 · strength 0.27
  10. Duncan R.C. Spalding · 4 shared papers, 2012–2019 · strength 0.25
  11. Adam Enver Frampton · 4 shared papers, 2012–2019 · strength 0.24
  12. Leandro Castellano · 3 shared papers, 2015–2019 · strength 0.21
  13. Nino Toria · 1 shared paper, 2022 · strength 0.17
  14. Tinatin Chikovani · 1 shared paper, 2022 · strength 0.17
  15. Patrick Varun Lawrence · 1 shared paper, 2022 · strength 0.16
  16. Hemant Mahendrakumar Kocher · 1 shared paper, 2022 · strength 0.16
  17. Sorah Yoon · 2 shared papers, 2016–2019 · strength 0.15
  18. John J. Rossi · 2 shared papers, 2016–2019 · strength 0.15
  19. Kai‐Wen Huang · 2 shared papers, 2016–2019 · strength 0.15
  20. Tamara Gall · 2 shared papers, 2015–2019 · strength 0.14
  21. Vinod P. Balachandran · 1 shared paper, 2020 · strength 0.13
  22. Harpreet Singh Wasan · 1 shared paper, 2020 · strength 0.13
  23. Justin Stebbing · 2 shared papers, 2015–2018 · strength 0.12
  24. Jonathan Krell · 2 shared papers, 2015–2018 · strength 0.12
  25. Elisa Giovannetti · 2 shared papers, 2015–2018 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.